Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
AeroRx Partners with HCmed to Develop a Nebulized LABA/LAMA Combination Solution for the Treatment of Chronic Obstructive Pulmonary Disease 2022-10-03 09:00
Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2022 2022-10-01 04:30
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022 2022-09-29 19:00
NeuShen Therapeutics Closes Pre-A Financing with ~$20M 2022-09-29 17:50
Kintor Pharma Announces Publication of Phase Ib Data from Pruxelutamide for AR+ mBC in EJC 2022-09-29 14:22
Simcere and Almirall Enter into a Licensing Agreement for IL-2 mu-Fc 2022-09-29 11:32
Zhongchao Inc. Establishes Chongqing Xinjiang Pharmaceutical Co., Ltd. to Improve Patient Access to Medications 2022-09-28 21:18
Samsung Biologics Earns Gold Rating from EcoVadis for Its Sustainability Efforts 2022-09-28 19:00
Harbour BioMed Announces First Subject Dosed in Phase I Study of Next-Gen Anti-TSLP Fully Human Monoclonal Antibody 2022-09-27 21:40
Angel Pharmaceuticals Announces Approval of IND Application for Phase 1/1b Clinical Trial of Mupadolimab (Anti-CD73) in China 2022-09-27 08:30
Fosun Pharma and MAIA Pharmaceuticals Jointly Announce the Successful Commercialization of Only FDA Approved 20ml Sodium Phenylacetate and Sodium Benzoate (SPSB) Liquid Product 2022-09-26 22:13
Bioheng Biotech Announces Publication of Impressive Results with CD7-targeted allogeneic CAR-T cell therapy for Relapsed or Refractory T Cell Malignancies 2022-09-26 21:00
PharmAbcine to Participate in BIO-Europe 2022 2022-09-26 20:00
WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility 2022-09-26 20:00
CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop "Off-the-Shelf" CAR-iMAC Cell Therapy 2022-09-26 12:31
111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee 2022-09-23 12:30
RVAC Medicines Initiates First-in-Human Clinical Trials for mRNA COVID-19 Vaccine Candidates 2022-09-22 10:00
Ascentage Pharma Announces Phase I/II Data of Olverembatinib (HQP1351) Published in the Journal of Hematology & Oncology, Further Validating the Drug's Best-in-Class Potential 2022-09-21 22:49
Charsire's New Drug Aims to Capture Multi-Billion-Dollar Dementia Treatment Market 2022-09-21 20:00
Mediaseek's Proprietary Neurofeedback Engine "Alpha Switch" and Its Smartphone Application Mentioned in International Journal 2022-09-21 14:00
1 67 68 69 70 71 165